. . . . . . . "[Given the distinct role of these pathways in the context of DC function, we propose that dual therapies targeted at both the CD40 and LT? receptor may have therapeutic potential in silencing DC-driven autoimmunity or in promoting tumor clearance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en . . . . . "2017-02-19"^^ . . "Gene-disease associations inferred from text-mining the literature."@en . "DisGeNET evidence - LITERATURE"@en . "2017-10-17T13:11:20+02:00"^^ . . . . . . . . . . . "v5.0.0.0" . "v5.0.0" .